PEBC Report - Programa de Epigenética y BiologÃa del Cáncer
PEBC Report - Programa de Epigenética y BiologÃa del Cáncer
PEBC Report - Programa de Epigenética y BiologÃa del Cáncer
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
SPEAKERS BIOGRAPHY AND ABSTRACT<br />
Peter W Andrews<br />
Peter Andrews, PhD, obtain a BSc in<br />
Biochemistry from the University of<br />
Leeds in 1971, and a D. Phil. in<br />
Genetics from the University of Oxford<br />
in 1975. Following postdoctoral<br />
research at the Institut Pasteur in Paris<br />
and the Sloan Kettering Institute in<br />
New York, he was a research scientist<br />
on the staff of the Wistar Institute of<br />
Anatomy and Biology in Phila<strong>de</strong>lphia<br />
from 1978 to 1992. In 1992 he was appointed to the Arthur<br />
Jackson Chair of Biomedical Research in the University of<br />
Sheffield, where he is currently co-director of the Centre for<br />
Stem Cell Biology. His research focuses on the biology of<br />
pluripotent human stem cells. Among his current activities<br />
he co-ordinates the International stem Cell Initiative, which is<br />
focused upon characterising standard markers and culture<br />
conditions for human ES cells. He is also the co-ordinator of<br />
ESTOOLS, a European Integrated Project of 21 partners<br />
un<strong>de</strong>r the sixth framework program.<br />
The Centre for Stem Cell Biology<br />
and Department of Biomedical Science,<br />
The University of Sheffield, UK<br />
Population Dynamics of Human ES Cell<br />
Cultures: Self-Renewal, Adaptation and Cancer<br />
of the population as a whole, without taking account of the<br />
consequent heterogeneity of such cultures. Further, a<br />
propensity for differentiation provi<strong>de</strong>s a basis for selective<br />
pressures that may lead to the appearance of variant ES<br />
cells that exhibit an increased probability of self renewal<br />
over differentiation, or cell <strong>de</strong>ath through apoptosis.<br />
In<strong>de</strong>ed human ES cell lines do tend to accumulate nonrandom<br />
genetic changes on prolonged culture. These<br />
genetic changes inclu<strong>de</strong> amplifications of chromosomes<br />
12, 17 and X similar to those seen in embryonal carcinoma<br />
(EC) cells, the stem cells of teratocarcinomas and the<br />
malignant counterparts of ES cells. Thus the progressive<br />
culture adaptation of human ES cells in culture provi<strong>de</strong>s a<br />
unique mo<strong>de</strong>l that may be pertinent to the progression of<br />
stem cell based cancers.<br />
Accumulating evi<strong>de</strong>nce suggests that the ‘stem cell compartment’<br />
in both ES and other stem cells, including cancer<br />
stem cells, may be composed of distinct substates.<br />
Another aspect of culture adaption of human ES cells is<br />
that it alters the population dynamics of ES cultures, particularly<br />
affecting the behavior of substates within the<br />
stem cell compartment. Un<strong>de</strong>rstanding the nature of<br />
these substates and their interactions may provi<strong>de</strong><br />
insights into the mechanisms that control self renewal,<br />
commitment to differentiation and lineage selection of ES<br />
and, ultimately iPS cells. Inevitably these same mechanisms<br />
may also play a role in cancer progression.<br />
A key feature of pluripotent stem cells is their ability to proliferate<br />
in<strong>de</strong>finitely while maintaining an ability to differentiate<br />
into all somatic cell types. Such proliferation is known as<br />
‘self-renewal’. However, these cells may also differentiate<br />
spontaneously, or in response to specific cues. When they<br />
divi<strong>de</strong>, stem cells must choose between self renewal and<br />
commitment to differentiation. Further, if they commit to differentiate<br />
they must choose between different lineages. An<br />
un<strong>de</strong>rstanding of the molecular mechanisms that control<br />
these <strong>de</strong>cision processes un<strong>de</strong>rlies any potential use of<br />
human embryonic stem (ES) cells, or iPS cells, whether in<br />
regenerative medicine or in other areas such as drug discovery,<br />
toxicology or disease mo<strong>de</strong>ling.<br />
Some <strong>de</strong>gree of spontaneous differentiation is common in<br />
cultures of human ES cells. This can confuse studies of<br />
human ES cell behavior if assays are based on assessment<br />
Selected Publications<br />
Andrews, P.W. (2002). From teratocarcinomas to embryonic<br />
stem cells. Phil. Trans. R. Soc. Lond. B 357, 405-417.<br />
Baker, D.E.C., Harrison, N.J., Maltby, E., Smith, K., Moore,<br />
H.D., Shaw, P.J., Heath, P.R., Hol<strong>de</strong>n, H., Andrews, P.W.,<br />
(2007) Adaptation to culture of human embryonic stem cells<br />
and oncogenesis in vivo. Nature Biotechnology 25: 207 –<br />
215.<br />
Draper J.S. Smith, K., Gokhale, P.J., Moore, H.D., Maltby, E.,<br />
Johnson, J., Meisner, L., Zwaka, T.P., Thomson, J.A.,<br />
Andrews, P.W. (2004) Karyotypic evolution of human<br />
Embryonic Stem (ES) cells in culture: recurrent gain of chromosomes<br />
17 (17q) and 12. Nat. Biotech. 22: 53-54<br />
Enver T, Soneji S, Joshi C, Iborra F, Orntoft T, Thykjaer T, Maltby<br />
E, Smith K, Abu Dawd R, Matin M, Gokhale P, Draper JS,<br />
Andrews, P.W. (2005) Cellular differentiation hierarchies in<br />
normal and culture adapted human embryonic stem cells.<br />
Human Mol Genet. 14: 1-12.<br />
13